Recursion Pharmaceuticals
Tracked across 1 events · 6 articles · First seen Jun 26, 2026 · Last active Jul 05, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Recursion Pharmaceuticals shares were acquired by ARK Investment Management, suggesting a contrarian bet on the company's growth despite its stock trading significantly below its 52-week high.
Jun 26, 2026 · 6 articles
70
Cathie Wood bought shares Recursion PharmaceuticalsCathie Wood Buys Growth Stocks
ERGEN INTELLIGENCE
Track Recursion Pharmaceuticals live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard